UP!

ARTX $3   View long term graphs

Arotech Corporation
Type
Public (NASDAQ: ARTX)
Industry Defense
Aerospace
Founded 1990; 27 years ago (1990)
Headquarters Delaware, United States
Key people
Steven Esses Chief Executive Officer
Revenue Increase US$ 103.5 million (2014)
Operating income
Increase US$ 3.5 million (2014)
Net income
Increase US$ 3.5 million (2014)
Number of employees
531
Website http://www.arotech.com/

Arotech Corporation is a defense and security products and services company. It manufactures and designs products for military and non-military air and ground vehicles; interactive simulation for military, law enforcement and commercial markets, and batteries and charging systems for the military. Arotech operates through two major business divisions: Interactive simulation for military, law enforcement and commercial markets, and batteries and power systems for the military.

Arotech is incorporated in Delaware, with corporate offices in Ann Arbor, Michigan and research, development and production subsidiaries in Michigan, South Carolina and Israel.

Raytheon Company remains Arotech's chief competitor in defense, homeland security and other government markets.

In 2004, Armour of America was acquired by Arotech Corporation. Arotech's armor division produces armored vehicles for homeland security and government agencies. It owns manufacturing facilities in Auburn, Alabama, and Lod, Israel. The company has designed armor for over 30 types of vehicles, including military vehicles, helicopters and transport aircraft. These include:

Arotech's Training and Simulation Division (FAAC) manufactures and markets advanced high-tech multimedia and interactive digital solutions for engineering, use-of-force, and driver training simulations for military, law enforcement, security, municipal and private industry personnel. The division also supplies pilot decision making support software for the F-15, F-16, F-18, F-22, and F-35 aircraft, as well as simulation models for the ACMI/TACTS air combat training ranges.

Arotech's simulation division has been awarded federal contracts for the Federal Bureau of Investigation (FBI), Drug Enforcement Administration (DEA), and Department of Health and Human Services (HHS). Robert McCue, director of Arotech's IES subsidiary, said "We know that the agencies that have selected our systems rely heavily on them to enhance the readiness of their agents as they confront increasing threats at home and abroad. We are proud to support them in that mission."

Subsidiaries of Arotech:

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q3 2019 2019-11-06 0.06 0.00
Q2 2019 2019-08-07 0.03 0.01
Q1 2019 2019-05-08 -0.03 -0.05
Q4 2018 2019-03-06 0.04 0.02
Q3 2018 2018-11-06 0.06 0.03
Q2 2018 2018-08-07 0.03 0.00
Q1 2018 2018-05-09 0.05 0.02
Q4 2017 2018-03-14 0.08 0.29
Q3 2017 2017-11-08 0.06 0.03
Q2 2017 2017-08-08 0.01 -0.02

Ratings

2016-03-19 Reiterated Rating B. Riley Buy $4.50
2016-03-14 Reiterated Rating B. Riley Buy $4.50
2015-11-14 Reiterated Rating B. Riley Buy $4.50
2015-11-09 Reiterated Rating B. Riley Buy $4.50
2015-08-15 Reiterated Rating B. Riley Buy $4.50
2015-08-10 Lower Price Target B. Riley Buy $5.50 to $4.50
2015-05-11 Reiterated Rating B. Riley Buy $5.50
2015-03-16 Reiterated Rating B. Riley Buy $5.50
2014-08-13 Boost Price Target B. Riley Buy $5.25 to $5.50
2014-05-12 Upgrade B. Riley Neutral to Buy $5.00
2014-03-11 Downgrade B. Riley Buy to Neutral $3.70 to $5.00
2013-10-02 Initiated Coverage B. Riley Buy
1970-01-01
2016-03-19 Reiterated Rating B. Riley Buy $4.50
2016-03-14 Reiterated Rating B. Riley Buy $4.50
2015-11-14 Reiterated Rating B. Riley Buy $4.50
2015-11-09 Reiterated Rating B. Riley Buy $4.50
2015-08-15 Reiterated Rating B. Riley Buy $4.50

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks
ESSES STEVEN D President and COO 4.94%  (1199513) ARTX /
EHRLICH ROBERT S Chairman and CEO 4.81%  (1169178) ARTX /
Paup Thomas J Vice President Finance and CFO 1.42%  (343946) ARTX /
Sloyer Elliot 0.95%  (231283) ARTX /
Marrus Michael E. 0.50%  (120903) ARTX /
Krutty Dean M Exec VP-N Am Ops & Acting CEO 0.49%  (118972) ARTX /
JONES SEYMOUR 0.38%  (91346) ARTX /
EASTMAN JAY M 0.38%  (91346) ARTX /
Cappell Kenneth W 0.35%  (84702) ARTX /
BOREY EDWARD J 0.30%  (71695) ARTX /
Leibowitz Arthur S 0.27%  (64638) ARTX /
Hagenbuch Lawrence F 0.21%  (51802) ARTX / REMY /
Kutler Jon B Lead Independent Director 0.20%  (48246) ARTX / TSYS /
Rudy Richard I 0.14%  (33403) ARTX /
Quinn James J 0.12%  (29988) ARTX /
Battershell Carol Jane 0.10%  (24907) ARTX /
MILLER LAWRENCE M 0.05%  (11281) ARTX /
ROSENFELD JACK E 0.04%  (10572) ARTX /

Comments